Merge Healthcare, a provider of medical imaging solutions, has reacquired its operations in China.
The sale of Cedara Software Shanghai to Inqgen Technology, initiated by former Merge executives in March 2008, has been terminated by mutual agreement of the parties.
“Earlier in 2008, Merge pursued the divestment of all of its international operations, including China. As we have discussed on our two prior earnings calls, we believe in the growth of our core business on an international scale and therefore terminated the planned divesture of our European operations in June,” said Justin Dearborn, CEO of the Milwaukee-based Merge. “We feel it is critical to have sales, marketing, customer support and an engineering presence in China to be successful.”
The Taipei, Taiwan-based Inqgen has participated in the transfer to date, working with employees of ShanghaiCo on the communication of transition plans, Merge said.
Zhong Wang, Asia business operations director of Merge OEM, has assumed management of the Shanghai operations.